Type 2 diabetes drug launches
STO-REC-STATX8M04DT2 National
6
China · 2025
Type 2 diabetes drug launches in China stood at 6 in 2025 (DIA).
- Publisher
- DIA
- Authority tier
- T2 National
- Locator
- The Cancer Sector Continues to Attract the Most Players
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
Among them, six new drugs were launched for type 2 diabetes (T2D), including the DPP-4 inhibitor prusogliptin, the anti-CD3 biologic teplizumab, the GLP-1R agonist efsubaglutide α, as well as the combination therapies retagliptin + henagliflozin + metformin and retagliptin + metformin.
Verbatim extraction verified: The figure 6 is directly attested in the quoted passage (The Cancer Sector Continues to Attract the Most Players).
The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.
- APA
- DIA. (2025). 2025 NMPA Approvals: China Clears Record Number of New Drugs. Retrieved September 17, 2026, from https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Via StatOrigin, https://statorigin.org/stat/stat_X8M04DZ4A1P892TV93P76ZFKA6
- MLA
- DIA. "2025 NMPA Approvals: China Clears Record Number of New Drugs." 2025, https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_X8M04DZ4A1P892TV93P76ZFKA6.
- Chicago
- DIA. "2025 NMPA Approvals: China Clears Record Number of New Drugs." 2025. https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_X8M04DZ4A1P892TV93P76ZFKA6.
- BibTeX
- @misc{dia2025type6zfka6, author = {{DIA}}, title = {2025 NMPA Approvals: China Clears Record Number of New Drugs}, year = {2025}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_X8M04DZ4A1P892TV93P76ZFKA6}, note = {Original source: https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed September 17, 2026.} }
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Chain of Custody · Verification Audit
Primary Source
- Publisher
- DIA · homepage ↗
- Authority tier
- Tier 2 · National Official
- Report
- 2025 NMPA Approvals: China Clears Record Number of New Drugs
- Type
- Press release
- Published
- —
- Locator
- The Cancer Sector Continues to Attract the Most Players
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification & Integrity
- Audit status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Archival URI
- /stat/stat_X8M04DZ4A1P892TV93P76ZFKA6